Latest Breaking News On - உலகளாவிய ஆரோக்கியம் வலைப்பின்னல் - Page 1 : comparemela.com
The effect of the Delta variant in uncertain times
thedailystar.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailystar.net Daily Mail and Mail on Sunday newspapers.
Largest ever Lassa fever study expands to more countries in West Africa
zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.
The CEPI centralised laboratory network: supporting COVID-19 vaccine development
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
The coronavirus is running riot and health systems are buckling in India
Credit: DANISH SIDDIQUI /REUTERS
As people in London, Tel Aviv and New York start to move past the excitement of getting coronavirus jabs and turn their thoughts to booking summer holidays, it might appear for many that the world is at last returning to normal.
In countries which have been able to harness the scientific marvel of rapidly-developed vaccines, the jabs have had a profound effect on future prospects.
With infections, hospitalisations and deaths plummeting and study after study highlighting the protective power of vaccines, forecasters are daring to predict the good times will roll again after a miserable 16 months.
Show more
Two weeks ago several G7 leaders called for an international treaty on Pandemic Preparedness for the future. This week 175 prominent leaders called for lifting the IP on vaccine design. And former UK PM Gordon Brown called on the G7 to finance vaccines for the world in the next two months. But are there technical difficulties that limit the pace of manufacture?
Anthony McDonnell is an economist at think tank Centre for Global Development who has been looking at the problem since last year. He suggests, amongst other things, one limit is the human expertise in manufacturing these brand-new technologies, with another being a level of vaccine nationalism that is seeing a lack of exports of components involved in manufacture.